Jamadagni, S., Pandkar, P., Saundankar, T., Shirke, G., Malekar, S., & Vaidya, V. (2022). Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial. Elsevier.
Цитирование в стиле Чикаго (17-е изд.)Jamadagni, Sameer, Prasad Pandkar, Tushar Saundankar, Girish Shirke, Shailesh Malekar, и V.G Vaidya. Efficacy of Madhav Rasayan Plus as Adjuvant in Moderate COVID-19 Patients: Preliminary Outcomes of Randomized Controlled Trial. Elsevier, 2022.
Цитирование MLA (9-е изд.)Jamadagni, Sameer, et al. Efficacy of Madhav Rasayan Plus as Adjuvant in Moderate COVID-19 Patients: Preliminary Outcomes of Randomized Controlled Trial. Elsevier, 2022.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.